Likewise, increased activity of serum glutamic oxaloacetate transminase (SGOT) and of serum glutamic pyruvate transminase (SGPT) in diabetes is of clinical importance[2] because elevated activity of SGOT is suggestive of cardiac damage and that of SGPT liver damage[3]. This evidence concerns the gene GOT1 and diabetes mellitus.